← Back to companies
Nabla Bio
0 open
Cambridge, Massachusetts, United StatesFounded 202021+ employeesSeries A raisedSeries APrivate
Last round: series a · $26M · May 2024(5 rounds total)
Founded by Frances Anastassacos, Surge Biswas
Backed by(9 investors)
Fifty YearsKhosla VenturesZetta Venture PartnersRadical VenturesNational Science FoundationY CombinatorBoom Capital VenturesCantos
Nabla Bio is building an end-to-end antibody creation platform. Nabla Bio is applying natural language processing algorithms to amino acids generating a predictive “biophysical fingerprint” for 1 million antibodies in a single step.
Open Positions at Nabla Bio (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Nabla Bio?
